Shop the same nominal peptide across a dozen sellers and you'll find a tenfold spread. Faced with that, most buyers reach for one of two heuristics: cheap means fake, or expensive means markup. Both are guesses dressed as reasoning, and the honest answer is less satisfying than either.
Price in this market is set by positioning, not by cost. Synthesis costs are real but they are a small and shrinking share of what a vial sells for. Volume, sourcing relationships, brand posture, channel, and margin appetite drive the rest — and none of those is a quality variable. Two sellers can list the same molecule from adjacent supply and price it 4× apart because one is selling to price-shoppers and the other to a boutique audience.
Why cheap doesn't mean bad
Some cheap material is genuinely bad. But cheap can also mean a seller with better volume economics, thinner margins, or a business that isn't paying for influencer placements. Low price is compatible with poor quality and with efficient operations, which is exactly what makes it useless as a signal on its own.
Why expensive doesn't mean good
This is the direction people underweight, and it deserves the harder look.
Nothing about charging more requires anyone to test anything. A premium price buys packaging, a nicer site, and a margin — none of which touch what's in the vial. The market has no mechanism forcing price and verification to move together, and a seller who spends the premium on brand rather than assay is running a more profitable business than one who spends it on lab work.
Expensive-therefore-rigorous is a story buyers tell themselves, and it's the one the industry is happiest to leave uncorrected.
What actually carries information
Documents. Specifically the boring, checkable ones:
- A certificate for your lot, not a representative example
- The laboratory's name, so the result is in principle verifiable
- Two methods — chromatography for purity, mass spectrometry for identity
- A recent date, because a certificate describes material at a moment
Any seller at any price point can produce these. Most at every price point don't. That's the actual dividing line in this market, and it runs sideways across price rather than along it.
The useful reframe
Stop asking "is this price right?" and start asking "what am I buying besides the molecule?"
Sometimes the answer is a real quality program with lab costs behind it. Sometimes it's a marketing budget. Sometimes it's neither and you've found efficient supply. The price alone will never tell you which — but the paperwork will, in about thirty seconds, for free.
We've written the certificate field guide because that check is the only part of this that's actually knowable.
Opinions are the publication's own. The Assay is published by Merit Sciences, which sells research compounds — a disclosure that applies with particular force to an article about pricing. Research use only.
For research use only · Not for human or veterinary use · No compound discussed here is FDA-approved for any indication